Seroprevalence of hepatitis C virus in voluntary blood donors at a tertiary care Hospital, Ahmedabad, India
Joint Authors
Tahiliani, Henisha Tulsidas
Purohit, Asha Poonamchand
Prajapati, Vipul Bachubhai
Jarwani, Puja Bhavesh
Source
Issue
Vol. 18, Issue 1 (31 Mar. 2021), pp.18-22, 5 p.
Publisher
University of Babylon College of Medicine
Publication Date
2021-03-31
Country of Publication
Iraq
No. of Pages
5
Main Subjects
Topics
Abstract EN
Background: Hepatitis C virus (HCV) is the most common cause of post transfusion non‑A, non‑B hepatitis worldwide.
The prevalence of HCV in blood donors in high‑income countries ranges from 0.002% to 0.05% , in middle‑income countries ranges from 0.03% to 0.80% , and in low‑income countries, prevalence varies from 0.50% to 2.23% .
Objectives: The objectives of this study are to assess the seroprevalence and the trend of HCV in healthy voluntary blood donors at a tertiary care hospital in Ahmedabad over a period of 3 years.
Settings and Design: Observational, retrospective study.
Materials and Methods: During January 2017 to December 2019, 9477 voluntary blood donors were tested for the presence of anti‑HCV antibody by using a 3rd‑generation enzyme‑linked immunosorbent assay test.
Statistical Analysis Used: Data were statistically analyzed by using the Chi‑square test, and Chi‑Square test for linear trends using the Statistical Package for the Social Sciences (SPSS) software trial version 19.
Results: Out of 9477 voluntary blood donors, 9229 (97.38% ) donors were male and 248 ( 2.62% ) were female.
Ten donors (0.11% ) were positive for anti‑HCV.
All seropositive donors were male.
Out of total 0.11% seropositive donors, maximum (0.07% ) were within the age group of 21–30 years.
Seroprevalence of HCV showed a statistically significant decreasing trend over 3 years.
Conclusion: Hepatitis C is a common cause of transfusion‑related hepatitis.
Early identification of persons with chronic HCV infection would enable infected persons to receive the necessary care and treatment to prevent or delay the onset of liver is the most common cause of post transfusion non‑A, non‑B hepatitis worldwide.
The prevalence of HCV in blood donors in high‑income countries ranges from 0.002% to 0.05% , in middle‑income countries ranges from 0.03% to 0.80% , and in low‑income countries, prevalence varies from 0.50% to 2.23% .
Objectives: The objectives of this study are to assess the seroprevalence and the trend of HCV in healthy voluntary blood donors at a tertiary care hospital in Ahmedabad over a period of 3 years.
Settings and Design: Observational, retrospective study.
Materials and Methods: During January 2017 to December 2019, 9477 voluntary blood donors were tested for the presence of anti‑HCV antibody by using a 3rd‑generation enzyme‑linked immunosorbent assay test.
Statistical Analysis Used: Data were statistically analyzed by using the Chi‑square test, and Chi‑Square test for linear trends using the Statistical Package for the Social Sciences (SPSS) software trial version 19.
Results: Out of 9477 voluntary blood donors, 9229 (97.38% ) donors were male and 248 ( 2.62% ) were female.
Ten donors (0.11% ) were positive for anti‑HCV.
All seropositive donors were male.
Out of total 0.11% seropositive donors, maximum (0.07% ) were within the age group of 21–30 years.
Seroprevalence of HCV showed a statistically significant decreasing trend over 3 years.
Conclusion: Hepatitis C is a common cause of transfusion‑related hepatitis.
Early identification of persons with chronic HCV infection would enable infected persons to receive the necessary care and treatment to prevent or delay the onset of liver disease.
American Psychological Association (APA)
Tahiliani, Henisha Tulsidas& Purohit, Asha Poonamchand& Prajapati, Vipul Bachubhai& Jarwani, Puja Bhavesh. 2021. Seroprevalence of hepatitis C virus in voluntary blood donors at a tertiary care Hospital, Ahmedabad, India. Medical Journal of Babylon،Vol. 18, no. 1, pp.18-22.
https://search.emarefa.net/detail/BIM-1248146
Modern Language Association (MLA)
Tahiliani, Henisha Tulsidas…[et al.]. Seroprevalence of hepatitis C virus in voluntary blood donors at a tertiary care Hospital, Ahmedabad, India. Medical Journal of Babylon Vol. 18, no. 1 (Jan. / Mar. 2021), pp.18-22.
https://search.emarefa.net/detail/BIM-1248146
American Medical Association (AMA)
Tahiliani, Henisha Tulsidas& Purohit, Asha Poonamchand& Prajapati, Vipul Bachubhai& Jarwani, Puja Bhavesh. Seroprevalence of hepatitis C virus in voluntary blood donors at a tertiary care Hospital, Ahmedabad, India. Medical Journal of Babylon. 2021. Vol. 18, no. 1, pp.18-22.
https://search.emarefa.net/detail/BIM-1248146
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 22
Record ID
BIM-1248146